Northern Financial Advisors Inc Bristol Myers Squibb CO Transaction History

Northern Financial Advisors Inc

  • $132 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$57.89 - $64.73 $26,513 - $29,646
458 Added 4.41%
10,855 $630 Million
Q2 2023

Jul 21, 2023
SELL
$63.71 - $70.74 $192,467 - $213,705
-3,021 Reduced 22.51%
10,397 $665 Million
Q1 2023

Apr 26, 2023
BUY
$65.71 - $74.53 $881,696 - $1 Million
13,418 New
13,418 $930 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Northern Financial Advisors Inc Portfolio

Follow Northern Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northern Financial Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email